Option chain shows key data for AEON Biopharma's stock options at various strike prices and expiration dates. Traders use this information to analyze potential trades and assess market sentiment for AEON Biopharma.

AEON Biopharma (AMEX:AEON) Stock, Option Chain

AEON Biopharma

AEON Biopharma Inc is a clinical stage biopharmaceutical company focused on developing of its proprietary botulinum toxin complex ABP-450 (prabotulinumtoxinA) injection for debilitating medical conditions, with an initial focus on the neurosciences market.

Oil,Refineries,And,Chemical,Plants,In,Industrial,Areas

News

Eurozone

Commodities

Intraday Update

Markets

Trading Ideas

AEON

BLRX

NUKK

SCPX

Dow Jumps Over 300 Points; US Industrial Production Beats Estimates

Intel, Cleanspark, Super Micro Computer, Upstart, Tesla: Why These 5 Stocks Are On Investors' Radars Today

Pre-Market Outlook

Movers

ANIP

BBAI

CFFI

DOYU

GCTK

LUXH

PMAX

QUBT

RIME

SANG

SIBN

SLXN

SOBR

SONM

TNXP

WHLR

Why Taiwan Semiconductor Shares Are Trading Higher By Around 5%; Here Are 20 Stocks Moving Premarket

wall street ai16

Equities

BHAT

FUBO

SPRC

Nasdaq Surges Over 200 Points; BioLineRx Shares Plummet

AEON Biopharma, Inc. Class A Common Stock

AEON Biopharma Inc

AEON CREDIT SERVICE ASIA by Aeon Credit Service Asia Company Ltd

AEON Co Ltd

AEON DELIGHT CO LTD by Aeon Delight Co., Ltd.

AEON DELIGHT Co Ltd

AEON FANTASY CO LTD by AEON Fantasy Co., Ltd.

AEON FINCL SVCS JPN ORD by Aeon Financial Services Co., Ltd.

AEON Financial Service Co Ltd

AEON Mall Co Ltd

AEON REIT INVT CORP by AEON REIT INVT CORP.

AEON REIT Investment Corp

Aeon Credit Service (Asia) Co Ltd

Press Releases

AEON Biopharma, Inc. Announces Reverse Stock Split

Health Care

AEON Biopharma, Inc. to Participate in the Leerink Global Healthcare Conference

Earnings

AEON Biopharma Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Corporate Update

Management

AEON Biopharma Announces CEO Transition

General

AEON Biopharma Appoints Industry Veteran Rob Bancroft as Chief Executive Officer

Financing

AEON Biopharma Reports Inducement Grants Under NYSE American LLC Company Guide Section 711

AEON Biopharma Announces NYSE American Acceptance of Plan to Regain Listing Compliance

AEON Biopharma Reports First Quarter 2025 Financial Results and Provides Corporate Update

AEON Biopharma to Present at the Aegis Capital Corp. Virtual Conference 2025

AIM ImmunoTech

Aptorum Group Limited - Class A Ordinary Shares

Aptorum Group

Aprea Therapeutics

Brainstorm Cell Therapeutics Inc. - Common Stock

Brainstorm Cell

BioXcel Therapeutics, Inc. - Common Stock

BioXcel Therapeutics

Channel Therapeutics Corporation Common Stock

Channel Therapeutics

Calidi Biotherapeutics, Inc. Common Stock

Calidi Biotherapeutics

Cosciens Biopharma

CEL-SCI

Cyclacel Pharmaceuticals, Inc. - Common Stock

Cyclacel Pharmaceuticals

Cyclerion Therapeutics, Inc. - Common Stock

Cyclerion Therapeutics

Dogwood Therapeutics, Inc. - Common Stock

Dogwood Therapeutics

Evogene

Genprex

GT Biopharma

HCW Biologics

IN8bio

Intensity Therapeutics, Inc. - Common Stock

Intensity Therapeutics

Kairos Pharma

PharmaCyte Biotech

Silexion Therapeutics Corp - Ordinary Shares

Silexion Therapeutics

Sensei Biotherapeutics, Inc. - Common Stock

Sensei Biotherapeutics

Alaunos Therapeutics, Inc. - Common Stock

Alaunos Therapeutics

Turnstone Biologics

XTL Biopharmaceuticals Ltd. - American Depositary Shares

XTL Biopharmaceuticals

HC Wainwright & Co.

Comments

AEON Biopharma

AEON Biopharma (AEON) Options

No option chain data available. Please try again later

Connect With Us

About Benzinga

Market Resources

Trading Tools & Education

Ring the Bell